Iovate claims challenged
This article was originally published in The Tan Sheet
Executive Summary
The Electronic Retailing Self-Regulation Program forum recommends Iovate Health Sciences modify or discontinue some claims for its Cylaris and Rapid Slim SX weight-loss products in two May 16 decisions. WellNx Life Sciences, a competing supplement company, challenged Iovate's claims for both Cissus quadrangularis-containing products in the self-regulatory forum. ERSP determines Iovate provides reasonable basis for claims such as "contains proven, clinical-strength ingredients" but available public research does not support Iovate's "World's Strongest Weight-Loss Formula" or "World's Fastest Weight-Loss Solution" claims. ERSP cautions Iovate's "lose up to 32 lbs in 8 weeks" claim for Cylaris arguably qualifies as an inherently misleading statement under FTC's Red Flag Guide on weight-loss claims (1"The Tan Sheet" April 17, 2006, p. 10)...
You may also be interested in...
FTC “Disappointed” By Abundance Of Red Flag Weight-Loss Ads
FTC is considering what steps it will take in response to a "disappointing" run of advertisements containing "red flag" weight-loss claims by the print media in recent months, according to Richard Cleland, assistant director of the commission's Division of Advertising Practices
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.